{
  "DOI": "10.1038/s41431-019-0424-3",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-019-0424-3",
  "alternative-id": [
    "424"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "26 August 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "19 March 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "6 April 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "3 May 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "HRA REC 227795/17CAG0183 approved."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-4383-6038",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Martin",
      "given": "Antony P.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pedra",
      "given": "Gabriel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Downing",
      "given": "Jennifer",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Collins",
      "given": "Brendan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Godman",
      "given": "Brian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alfirevic",
      "given": "Ana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pirmohamed",
      "given": "Munir",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lynn Greenhalgh",
      "given": "Kathryn",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        5,
        3
      ]
    ],
    "date-time": "2019-05-03T15:04:24Z",
    "timestamp": 1556895864000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T20:59:56Z",
    "timestamp": 1684616396000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000272",
      "award": [
        "CLAHRC NWC 045"
      ],
      "doi-asserted-by": "publisher",
      "name": "DH | National Institute for Health Research"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        5,
        21
      ]
    ],
    "date-time": "2023-05-21T04:29:21Z",
    "timestamp": 1684643361024
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2019,
        5,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2019,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            5,
            3
          ]
        ],
        "date-time": "2019-05-03T00:00:00Z",
        "timestamp": 1556841600000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            5,
            3
          ]
        ],
        "date-time": "2019-05-03T00:00:00Z",
        "timestamp": 1556841600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-019-0424-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0424-3",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0424-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1351-1360",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2019,
        5,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        5,
        3
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.ejca.2012.12.027",
      "author": "J Ferlay",
      "doi-asserted-by": "publisher",
      "first-page": "1374",
      "journal-title": "Eur J Cancer",
      "key": "424_CR1",
      "unstructured": "Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403. https://doi.org/10.1016/j.ejca.2012.12.027",
      "volume": "49",
      "year": "2013"
    },
    {
      "DOI": "10.3322/caac.21203",
      "author": "C DeSantis",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "CA Cancer J Clin",
      "key": "424_CR2",
      "unstructured": "DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–32. https://doi.org/10.3322/caac.21203",
      "volume": "64",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ygyno.2012.12.016",
      "author": "G Chornokur",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "Gynecol Oncol",
      "key": "424_CR3",
      "unstructured": "Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129:258–64. https://doi.org/10.1016/j.ygyno.2012.12.016",
      "volume": "129",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12916-015-0405-5",
      "author": "T Lloyd",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Med",
      "key": "424_CR4",
      "unstructured": "Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–10. BMC Med. 2015;13:1–10. https://doi.org/10.1186/s12916-015-0405-5",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jacr.2016.10.003",
      "author": "ET Rosenthal",
      "doi-asserted-by": "publisher",
      "first-page": "561",
      "journal-title": "J Am Coll Radiol",
      "key": "424_CR5",
      "unstructured": "Rosenthal ET, Evans B, Kidd J, Brown K, Gorringe H, van Orman M, et al. Increased identification of candidates for high-risk breast cancer screening through expanded genetic testing. J Am Coll Radiol. 2017;14:561–8. https://doi.org/10.1016/j.jacr.2016.10.003",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2012.43.1882",
      "author": "E Castro",
      "doi-asserted-by": "publisher",
      "first-page": "1748",
      "journal-title": "J Clin Oncol",
      "key": "424_CR6",
      "unstructured": "Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748–57. https://doi.org/10.1200/JCO.2012.43.1882",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13053-015-0038-x",
      "author": "H Cavanagh",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "424_CR7",
      "unstructured": "Cavanagh H, Rogers KMA. The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers. Hered Cancer Clin Pract. 2015;13:1–7. https://doi.org/10.1186/s13053-015-0038-x",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2016.93",
      "author": "D Stoppa-Lyonnet",
      "doi-asserted-by": "publisher",
      "first-page": "S3",
      "issue": "S1",
      "journal-title": "Eur J Hum Genet",
      "key": "424_CR8",
      "unstructured": "Stoppa-Lyonnet D. The biological effects and clinical implications of BRCA mutations: where do we go from here? Eur J Hum Genet. 2016;24(S1):S3–S9. https://doi.org/10.1038/ejhg.2016.93",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMra1503523",
      "author": "LC Hartmann",
      "doi-asserted-by": "publisher",
      "first-page": "454",
      "journal-title": "N Engl J Med",
      "key": "424_CR9",
      "unstructured": "Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med. 2016;374:454–68. https://doi.org/10.1056/NEJMra1503523",
      "volume": "374",
      "year": "2016"
    },
    {
      "DOI": "10.1093/annonc/mdw327",
      "author": "S Paluch-Shimon",
      "doi-asserted-by": "publisher",
      "first-page": "v103",
      "issue": "Supplement 5",
      "journal-title": "Ann Oncol",
      "key": "424_CR10",
      "unstructured": "Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, et al. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening. Ann Oncol. 2016;27(Supplement 5):v103–v110. https://doi.org/10.1093/annonc/mdw327",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1093/jnci/djx265",
      "author": "R Manchanda",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "JNCI J Natl Cancer Inst",
      "key": "424_CR11",
      "unstructured": "Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, et al. Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. JNCI J Natl Cancer Inst. 2018;110:1–12. https://doi.org/10.1093/jnci/djx265",
      "volume": "110",
      "year": "2018"
    },
    {
      "key": "424_CR12",
      "unstructured": "Jolie A. My Medical Choice. The New York Times. 2013. http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html."
    },
    {
      "DOI": "10.1186/s12885-016-2472-1",
      "author": "C Staudigl",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Cancer",
      "key": "424_CR13",
      "unstructured": "Staudigl C, Pfeiler G, Hrauda K, Renz R, Berger A, Lichtenschopf R, et al. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect.”. BMC Cancer. 2016;16:436 https://doi.org/10.1186/s12885-016-2472-1",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13058-014-0442-6",
      "author": "DGR Evans",
      "doi-asserted-by": "publisher",
      "journal-title": "Breast Cancer Res",
      "key": "424_CR14",
      "unstructured": "Evans DGR, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, et al. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014;16:442 https://doi.org/10.1186/s13058-014-0442-6",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1136/bmj.i6357",
      "doi-asserted-by": "publisher",
      "key": "424_CR15",
      "unstructured": "Desai S, Jena AB. Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie’s New York Times editorial. Bmj. 2016:i6357. https://doi.org/10.1136/bmj.i6357"
    },
    {
      "key": "424_CR16",
      "unstructured": "NICE. Familial breast cancer: the classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. Clinical Guideline 164. London; 2013. http://guidance.nice.org.uk/CG164."
    },
    {
      "DOI": "10.1136/bmj.k764",
      "doi-asserted-by": "publisher",
      "key": "424_CR17",
      "unstructured": "Exarchakou A, Rachet B, Belot A, Maringe C, Coleman MP. Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study. Bmj. 2018:k764. https://doi.org/10.1136/bmj.k764"
    },
    {
      "DOI": "10.1016/S0140-6736(96)07495-8",
      "doi-asserted-by": "crossref",
      "key": "424_CR18",
      "unstructured": "Murray C, Lopez A. Global mortality, disability and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(1436–42.)."
    },
    {
      "DOI": "10.1016/S0140-6736(15)00195-6",
      "author": "JN Newton",
      "doi-asserted-by": "publisher",
      "first-page": "2257",
      "journal-title": "Lancet",
      "key": "424_CR19",
      "unstructured": "Newton JN, Briggs ADM, Murray CJL, Dicker D, Foreman KJ, Wang H, et al. Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2257–74. https://doi.org/10.1016/S0140-6736(15)00195-6",
      "volume": "386",
      "year": "2015"
    },
    {
      "key": "424_CR20",
      "unstructured": "PHE. The NHS atlas of variation in diagnostic services: reducing unwarranted variation to increase value and improve quality. London; 2013. www.rightcare.nhs.uk."
    },
    {
      "key": "424_CR21",
      "unstructured": "Kroese M, Deller J, Dew C, Murrary P, Salah S, Danks R, et al. Genetic test activity in England \u0026 Scotland. NHS UKGTN.1- 73. 2018. https://ukgtn.nhs.uk/fileadmin/uploads/ukgtn/Documents/Resources/Library/Reports_Guidelines/NHS_Directory_of_Genetic_Testing/UKGTN_Genetic_test_activity_final_July_2018"
    },
    {
      "DOI": "10.1136/bmjopen-2016-013318",
      "author": "H Pinnock",
      "doi-asserted-by": "publisher",
      "first-page": "e013318",
      "journal-title": "BMJ Open",
      "key": "424_CR22",
      "unstructured": "Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document. BMJ Open. 2017;7:e013318 https://doi.org/10.1136/bmjopen-2016-013318",
      "volume": "7",
      "year": "2017"
    },
    {
      "key": "424_CR23",
      "unstructured": "National Institute for Health and Care Excellence. Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Clinical guideline 2004;14. http://guidance.nice.org.uk/CG14."
    },
    {
      "key": "424_CR24",
      "unstructured": "National Institute for Health and Care Excellence. Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Clinical guideline 2006;41. http://guidance.nice.org.uk/CG41."
    },
    {
      "DOI": "10.1136/bmj.f3829",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "journal-title": "BMJ",
      "key": "424_CR25",
      "unstructured": "Evans DG, Graham J, O’Connell S, Arnold S, Fitzsimmons D. Familial breast cancer: summary of updated NICE guidance. BMJ . 2013;346:4–7. https://doi.org/10.1136/bmj.f3829",
      "volume": "346",
      "year": "2013"
    },
    {
      "DOI": "10.1136/bmj.322.7293.1052",
      "author": "JP Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1052",
      "journal-title": "BMJ",
      "key": "424_CR26",
      "unstructured": "Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ. 2001;322:1052–6. https://doi.org/10.1136/bmj.322.7293.1052",
      "volume": "322",
      "year": "2001"
    },
    {
      "DOI": "10.1136/bmj.c1191",
      "doi-asserted-by": "publisher",
      "key": "424_CR27",
      "unstructured": "Marmot M. Fair Society Healthy Lives (The Marmot Review). London; 2010. https://doi.org/10.1136/bmj.c1191"
    },
    {
      "DOI": "10.1093/pubmed/fdt031",
      "author": "B Eberth",
      "doi-asserted-by": "publisher",
      "first-page": "72",
      "journal-title": "J Public Heal (U Kingd)",
      "key": "424_CR28",
      "unstructured": "Eberth B, Olajide D, Craig P, Ludbrook A. Smoking-related disease risk, area deprivation and health behaviours. J Public Heal (U Kingd). 2014;36:72–80. https://doi.org/10.1093/pubmed/fdt031",
      "volume": "36",
      "year": "2014"
    },
    {
      "key": "424_CR29",
      "unstructured": "Department for Communities and Local Government. English indices of deprivation 2015. https://www.gov.uk/government/statistics/english-indices-ofdeprivation-2015. (Accessed 2 May 2019)."
    },
    {
      "key": "424_CR30",
      "unstructured": "Office for National Statistics. Lower layer super output area population estimates. 2018. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/lowersuperoutputareamidyearpopulationestimates."
    },
    {
      "key": "424_CR31",
      "unstructured": "Department of Health. The NHS Constitution for England. 2015. https://www.gov.uk/ government/publications/the-nhs-constitution-for-england/the-nhsconstitution-forengland. (Accessed 2 May 2019)."
    },
    {
      "DOI": "10.1093/ije/dyw098",
      "author": "JL Bernal",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Int J Epidemiol",
      "key": "424_CR32",
      "unstructured": "Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46:348–55. https://doi.org/10.1093/ije/dyw098",
      "volume": "46",
      "year": "2017"
    },
    {
      "DOI": "10.1046/j.1365-2710.2002.00430.x",
      "author": "A Wagner",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "journal-title": "J Clin Pharm Ther",
      "key": "424_CR33",
      "unstructured": "Wagner A, Soumerai S, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299–309. https://doi.org/10.1046/j.1365-2710.2002.00430.x",
      "volume": "27",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.jclinepi.2008.08.007.Methods",
      "author": "F Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Clin Epidemiol",
      "key": "424_CR34",
      "unstructured": "Zhang F, Wagner AK, Soumerai SB, Ross-degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2013;62:1–11. https://doi.org/10.1016/j.jclinepi.2008.08.007.Methods",
      "volume": "62",
      "year": "2013"
    },
    {
      "key": "424_CR35",
      "unstructured": "R: A language and environment for statistical computing. Vienna: Development Core Team; 2008."
    },
    {
      "DOI": "10.1038/srep29506",
      "author": "A George",
      "doi-asserted-by": "publisher",
      "journal-title": "Sci Rep",
      "key": "424_CR36",
      "unstructured": "George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, et al. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep. 2016;6:29506 https://doi.org/10.1038/srep29506",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ygyno.2017.01.030",
      "author": "M Kentwell",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Gynecol Oncol",
      "key": "424_CR37",
      "unstructured": "Kentwell M, Dow E, Antill Y, Wrede CD, Mcnally O, Higgs E, et al. Gynecologic oncology mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecol Oncol. 2017;145:1–7. https://doi.org/10.1016/j.ygyno.2017.01.030",
      "volume": "145",
      "year": "2017"
    },
    {
      "DOI": "10.1136/jmedgenet-2016-103902",
      "author": "I Plaskocinska",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Med Genet",
      "key": "424_CR38",
      "unstructured": "Plaskocinska I, Shipman H, Drummond J, Thompson E, Buchanan V, Newcombe B, et al. New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study. J Med Genet. 2016;2013:1–7. https://doi.org/10.1136/jmedgenet-2016-103902",
      "volume": "2013",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMoa1706450",
      "author": "M Robson",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "journal-title": "N Engl J Med",
      "key": "424_CR39",
      "unstructured": "Robson M, Im S-A, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377:523–33. https://doi.org/10.1056/NEJMoa1706450",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S1470-2045(14)70228-1",
      "author": "J Ledermann",
      "doi-asserted-by": "publisher",
      "first-page": "852",
      "journal-title": "Lancet Oncol",
      "key": "424_CR40",
      "unstructured": "Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, et al. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol. 2014;15:852–61. https://doi.org/10.1016/S1470-2045(14)70228-1",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10897-018-0261-5",
      "doi-asserted-by": "publisher",
      "key": "424_CR41",
      "unstructured": "Wright S, Porteous M, Stirling D, Lawton J, Young O, Gourley C, et al. Patients’ views of treatment-focused genetic testing (TFGT): some lessons for the mainstreaming of BRCA1 and BRCA2 testing. J Genet Couns. 2018:1–14. https://doi.org/10.1007/s10897-018-0261-5"
    },
    {
      "key": "424_CR42",
      "unstructured": "NICE. Final appraisal determination olaparib for maintenance treatment of relapsed, platinum-sensitive, brca mutation-positive ovarian, fallopian tube and peritoneal cancer after response to second-line or subsequent platinum-based chemotherapy. 2015. (Technology appraisal guidance 381). http://nice.org.uk/guidance/ta381"
    },
    {
      "DOI": "10.1097/GIM.0b013e3182091ba4.Underutilization",
      "author": "DE Levy",
      "doi-asserted-by": "publisher",
      "first-page": "349",
      "journal-title": "Genet Med",
      "key": "424_CR43",
      "unstructured": "Levy DE, Byfield SD, Comstock CB, Judy E, Syngal S, Crown WH, et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011;13:349–55. https://doi.org/10.1097/GIM.0b013e3182091ba4.Underutilization",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ygyno.2017.10.034",
      "author": "E Manrriquez",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "journal-title": "Gynecol Oncol",
      "key": "424_CR44",
      "unstructured": "Manrriquez E, Chapman JS, Mak J, Blanco AM, Chen L. May. Disparities in genetics assessment for women with ovarian cancer: can we do better?. Gynecol Oncol. 2018;149:84–88. https://doi.org/10.1016/j.ygyno.2017.10.034",
      "volume": "149",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cncr.28966.Attitudes",
      "author": "R Yusuf",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Cancer",
      "key": "424_CR45",
      "unstructured": "Yusuf R, Rogith D, Hovick S, Peterson S, Burton-Chase A, Fellman D, et al. Attitudes towards molecular testing for personalized cancer therapy. Cancer. 2015;121:243–50. https://doi.org/10.1002/cncr.28966.Attitudes",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ajmg.a.37455",
      "author": "C Burns",
      "doi-asserted-by": "publisher",
      "first-page": "418",
      "journal-title": "Am J Med Genet Part A",
      "key": "424_CR46",
      "unstructured": "Burns C, Mcgaughran J, Davis A, Semsarian C, Ingles J. Factors influencing uptake of familial long QT syndrome genetic testing. Am J Med Genet Part A. 2016;170:418–25. https://doi.org/10.1002/ajmg.a.37455",
      "volume": "170",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.jval.2014.09.001",
      "author": "V Kilambi",
      "doi-asserted-by": "publisher",
      "first-page": "838",
      "journal-title": "Value Heal",
      "key": "424_CR47",
      "unstructured": "Kilambi V, Johnson FR, González JM, Mohamed AF. Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening. Value Heal. 2014;17:838–45. https://doi.org/10.1016/j.jval.2014.09.001",
      "volume": "17",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.07.005",
      "author": "I Schrijver",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "J Mol Diagn",
      "key": "424_CR48",
      "unstructured": "Schrijver I, Pique L, Graham S, Pearl M, Cherry A, Kharrazi M. The spectrum of CFTR variants in nonwhite cystic fibrosis patients: implications for molecular diagnostic testing. J Mol Diagn. 2016;18:39–50. https://doi.org/10.1016/j.jmoldx.2015.07.005",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1377/hlthaff.2015.1476",
      "author": "CE Smith",
      "doi-asserted-by": "publisher",
      "first-page": "1367",
      "journal-title": "Health Aff",
      "key": "424_CR49",
      "unstructured": "Smith CE, Fullerton SM, Dookeran KA, Hampel H, Tin A, Maruthur NM, et al. Using genetic technologies to reduce, rather than widen, health disparities. Health Aff. 2016;35:1367–73. https://doi.org/10.1377/hlthaff.2015.1476",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10897-014-9712-9",
      "author": "K Sweeny",
      "doi-asserted-by": "publisher",
      "first-page": "263",
      "journal-title": "J Genet Couns",
      "key": "424_CR50",
      "unstructured": "Sweeny K, Ghane A, Legg AM, Huynh HP, Andrews SE. Predictors of genetic testing decisions: a systematic review and critique of the literature. J Genet Couns. 2014;23:263–88. https://doi.org/10.1007/s10897-014-9712-9",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2013.181",
      "author": "DLG Borzekowski",
      "doi-asserted-by": "publisher",
      "first-page": "516",
      "journal-title": "Genet Med",
      "key": "424_CR51",
      "unstructured": "Borzekowski DLG, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med. 2014;16:516–21. https://doi.org/10.1038/gim.2013.181",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s12687-017-0295-7",
      "doi-asserted-by": "publisher",
      "key": "424_CR52",
      "unstructured": "Roberts MC, Dusetzina SB. The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use. J Community Genet. 2017:141–6. https://doi.org/10.1007/s12687-017-0295-7"
    },
    {
      "DOI": "10.1016/j.jclinepi.2014.12.018",
      "author": "R Jandoc",
      "doi-asserted-by": "publisher",
      "first-page": "950",
      "journal-title": "J Clin Epidemiol",
      "key": "424_CR53",
      "unstructured": "Jandoc R, Burden AM, Mamdani M, Lévesque LE, Cadarette SM. Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations. J Clin Epidemiol. 2015;68:950–6. https://doi.org/10.1016/j.jclinepi.2014.12.018",
      "volume": "68",
      "year": "2015"
    }
  ],
  "reference-count": 53,
  "references-count": 53,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-019-0424-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Trends in BRCA testing and socioeconomic deprivation"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "27"
}